Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism
Authors:
- Karen Louise ThomsenKTKaren Louise Thomsen
- Thomas Damgaard SandahlTSThomas Damgaard Sandahl
- Peter Holland-FischerPHPeter Holland-Fischer
- Niels JessenNJNiels Jessen
- Jan FrystykJFJan Frystyk
- Allan FlyvbjergAFAllan Flyvbjerg
- Henning GrønbækHGHenning Grønbæk
- Hendrik VilstrupHVHendrik Vilstrup
- 1 December 2012
- journal article
- Published by Elsevier in Clinical Nutrition
- Vol. 31 (6) , 940-945
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Role of Body Fat Distribution and the Metabolic Complications of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Obesity, Inflammation, and Vascular Disease2007
- Adipose Tissue as an Endocrine OrganObesity, 2006
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Plasma Ghrelin Concentrations, Food Intake, and Anorexia in Liver FailureThe Journal of Clinical Endocrinology & Metabolism, 2004
- Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolismJournal of Hepatology, 2004
- Evaluation of nutritional practice in hospitalized cirrhotic patientsNutrition, 2003
- Nutrition and survival in patients with liver cirrhosisNutrition, 2001
- Hypermetabolism in clinically stable patients with liver cirrhosisThe American Journal of Clinical Nutrition, 1999